The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
MYC and tumor metabolism: chicken and egg
Open accessAbstract
Transcription factors of the MYC family are deregulated in the majority of all human cancers. Oncogenic levels of MYC reprogram cellular metabolism, a hallmark of cancer development, to sustain the high rate of proliferation of cancer cells. Conversely, cells need to modulate MYC function according to the availability of nutrients, in order to avoid a metabolic collapse. Here, we review recent evidence that the multiple interactions of MYC with cell metabolism are mutual and review mechanisms that control MYC levels and function in response to metabolic stress situations. The main hypothesis we put forward is that regulation of MYC levels is an integral part of the adaptation of cells to nutrient deprivation. Since such mechanisms would be particularly relevant in tumor cells, we propose that-in contrast to growth factor-dependent controls-they are not disrupted during tumorigenesis and that maintaining flexibility of expression is integral to MYC's oncogenic function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many tumors driven by oncogenic KRAS and its downstream effector, the transcription factor MYC, exhibit metabolic reprogramming to consume and rely more on glutamine for both catabolic to anabolic pathways55,56.”
From The metabolic landscape of RAS-driven cancers from biology to therapy (2021) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Csibi, A., Lee, G., Yoon, S.-O., Tong, H., Ilter, D., Elia, I., Fendt, S., Roberts, T. M., & Blenis, J. (2014) · Current Biology · doi:10.1016/j.cub.2014.08.007 · Cited by 253
RetractedShi, Y., Yang, Y., Hoang, B. Q., Bardeleben, C., Holmes, B., Gera, J., & Lichtenstein, A. K. (2015) · Oncogene · doi:10.1038/onc.2015.156 · Cited by 68
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
Endoplasmic reticulum stress: cell life and death decisions
Xu, C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26373 · Cited by 2,291
The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation
Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.021 · Cited by 2,140 · cited 2×
“In activated T cells, MYC increases the expression of G6PDH, encoding for glucose-6phosphate dehydrogenase, which catalyzes the first reaction of the oxidative phase, and TKT, which encodes for transketolase, an enzyme of the non-oxidative branch (Wang et al, 2011).”
BackgroundInsights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins
Castello, A., Fischer, B., Eichelbaum, K., Horos, R., Beckmann, B. M., Strein, C., Davey, N. E., Humphreys, D. T., Preiss, T., Steinmetz, L. M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.031 · Cited by 2,132
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 247
Directly targeting c-Myc contributes to the anti-multiple myeloma effect of anlotinib
Cao, Y., Shan, H., Liu, M., Liu, J., Zhang, Z., Xu, X., Liu, Y., Xu, H., Lei, H., Yu, M., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03685-w · Cited by 21
Targeting the cholesterol-RORα/γ axis inhibits colorectal cancer progression through degrading c-myc
Wang, Y., Ruan, D., Wang, Z., Yu, K., Rong, D., Liu, Z., Wang, F., Hu, J., Jin, Y., Wu, Q., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02515-3 · Cited by 20
USP36 protects proximal tubule cells from ischemic injury by stabilizing c-Myc and SOD2
Liu, Q., Sheng, W., Ma, Y., Zhen, J., Roy, S., Jafar, C. A., Xin, W., & Wan, Q. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.043 · Cited by 20
Mo, X., Shen, X., Mo, X., Yu, F., Tan, W., Deng, Z., He, J., Luo, Z., Chen, Z., & Yang, J. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115446 · Cited by 19
Ma, X., Han, X., Wang, W., Zhang, Q., & Tang, H. (2023) · Poultry Science · doi:10.1016/j.psj.2023.103377 · Cited by 19
Protein kinase C-iota-mediated glycolysis promotes non-small-cell lung cancer progression
Liu, L., Lei, B., Wang, L., Chang, C., Yang, H., Liu, J., Huang, G., & Xie, W. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s207211 · Cited by 19
Wang, Z., Fu, M., & Li, Y. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0495 · Cited by 19
Insights about MYC and Apoptosis in B-Lymphomagenesis: An Update from Murine Models
Vecchio, E., Fiume, G., Correnti, S., Romano, S., Iaccino, E., Mimmi, S., Maisano, D., Nisticò, N., & Quinto, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124265 · Cited by 19
Abudureheman, T., Xia, J., Li, M., Zhou, H., Zheng, W., Zhou, N., Shi, R., Zhu, J., Yang, L., Chen, L., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.663360 · Cited by 18
Fan, P., & Jordan, V. C. (2022) · Targeted Oncology · doi:10.1007/s11523-022-00870-5 · Cited by 18
Proteins moonlighting in tumor metabolism and epigenetics
Lv, L., & Lei, Q. (2021) · Frontiers of Medicine · doi:10.1007/s11684-020-0818-1 · Cited by 18
Chromosomal Instability as Enabling Feature and Central Hallmark of Breast Cancer
Castellanos, G., Valbuena, D. S., Pérez, E., Villegas, V. E., & Rondón‐Lagos, M. (2023) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s383759 · Cited by 22
Giannopoulou, A. F., Konstantakou, E. G., Velentzas, A. D., Avgeris, S. N., Avgeris, M., Papandreou, N. C., Zoi, I., Filippa, V., Katarachia, S. A., Lampidonis, A. D., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040937 · Cited by 16
PDGFRβ modulates aerobic glycolysis in osteosarcoma HOS cells via the PI3K/AKT/mTOR/c-Myc pathway
Tang, H., Guo, J., Sang, B., Cheng, J., & Wu, X. (2021) · Biochemistry and Cell Biology · doi:10.1139/bcb-2021-0305 · Cited by 17
Savvidou, I., Khong, T. T., Whish, S., Carmichael, I., Sepehrizadeh, T., Mithraprabhu, S., Horrigan, S. K., de Veer, M., & Spencer, A. G. (2022) · Cancers · doi:10.3390/cancers14030840 · Cited by 16
Fang, Y.-X., Lu, E.-Q., Cheng, Y.-J., Xu, E., Zhu, M., & Chen, X. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c08701 · Cited by 16
Guo, M. Z., Li, X., Tao, W., Teng, F., & Li, C. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012463 · Cited by 16
Wang, H., Wang, J., Liu, J., Wang, Y., Xia, G., & Huang, X. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110282 · Cited by 16
Chen, Z., Han, C., Zhou, X., Wang, X., Liao, X., He, Y., Mo, S., Li, X., Zhu, G., Ye, X., et al. (2021) · Translational Cancer Research · doi:10.21037/tcr-20-3056 · Cited by 15
Zormpas‐Petridis, K., Jerome, N. P., Blackledge, M., Carceller, F., Poon, E., Clarke, M., McErlean, C. M., Barone, G., Koers, A., Vaidya, S. J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3412 · Cited by 15
Non-coding RNAs, metabolic stress and adaptive mechanisms in cancer
Liu, X., Feng, S., Zhang, X. D., Li, J., Zhang, K., Wu, M., & Thorne, R. F. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.06.024 · Cited by 15
Claiborne, M. D., & Leone, R. D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1011191 · Cited by 16
Guo, Z., Wang, Y., Zhao, Y., Jin, Y., An, L., Xu, H., Liu, Z., Chen, X., Zhou, H., Wang, H., et al. (2018) · Journal of Cancer · doi:10.7150/jca.28534 · Cited by 15
Sato, Y., Matsuda, S., Maruyama, A., Nakayama, J., Miyashita, T., Udagawa, H., Umemura, S., Yanagihara, K., Ochiai, A., Tomita, M., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01129 · Cited by 15
Zhang, W., Zhang, Y., Zhou, W., Qian, F., Hu, M., Chen, Y., Lü, J., Lou, Y., & Han, B. (2021) · Cancer Cell International · doi:10.1186/s12935-020-01714-w · Cited by 13
Lin, X., Zheng, J., Cai, X., Liu, L., Jiang, S., Liu, Q., & Sun, Y. (2024) · BMC Cancer · doi:10.1186/s12885-024-12327-1 · Cited by 13
Zhao, C., Zhao, F., Yang, L., Wang, Y., Wang, H., Fang, F., Zuo, H., Li, Z., He, G., Zhan, W., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00272 · Cited by 13
Yang, X., Zhang, Q., Li, S., Devarajan, R., Luo, B., Tan, Z., Wang, Z., Giannareas, N., Wenta, T., Ma, W., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02745-7 · Cited by 12
Co-overexpression of RIOK1 and AKT1 as a prognostic risk factor in glioma
Wang, Y., Xie, X., Li, S., Zhang, D., Zheng, H., Zhang, M., & Zhang, Z. (2021) · Journal of Cancer · doi:10.7150/jca.60596 · Cited by 12
Polydatin: A natural compound with multifaceted anticancer properties
Imtiyaz, K., Shafi, M., Fakhri, K. U., Uroog, L., Zeya, B., Anwer, S. T., & Rizvi, M. M. A. (2024) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2024.06.006 · Cited by 15
Tyagi, K., Roy, A., & Mandal, S. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09918-3 · Cited by 12
Liu, J., Hua, R., Fu, W., Zhu, J., Jia, W., Zhang, J., Zhou, H., Cheng, J., Xia, H., Liu, G., et al. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.08.31 · Cited by 11
Gan, L., Ren, Y., Lu, J., Ma, J., Shen, X., & Zhuang, Z. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s273108 · Cited by 12
Liu, S., Deng, Y., Yu, Y., & Xia, X. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.03.034 · Cited by 12
Agarwal, P., Glowacka, A., Mahmoud, L., Bazzar, W., Larsson, L., & Alzrigat, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098141 · Cited by 12
McGuire, T. R., Coulter, D. W., Bai, D., Sughroue, J. A., Li, J., Yang, Z., Qiao, Z., Liu, Y., Murry, D. J., Chhonker, Y. S., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-6033-2 · Cited by 12
Correlation of Glucose Metabolism with Cancer and Intervention with Traditional Chinese Medicine
Lai, G., Wang, F., Nie, D., Lei, S., Wu, Z., Cao, J., & Tang, L.-L. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/2192654 · Cited by 13
Raj, A. S. W. W., & Manoharan, R. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167508 · Cited by 11
Ren, T., Fan, X., Wang, M., Duan, F., Wei, C., Li, R., Jiang, Z., Wang, Y., Yao, X., Chen, M., et al. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4940 · Cited by 11
Tong, W., Wang, S., He, C., Li, A., Nie, J., Wei, Z., Yang, F., & Liu, Z. (2023) · Journal of Cancer · doi:10.7150/jca.83106 · Cited by 12
Zhang, X., Wu, K., Huang, Y., Xu, L., Li, X., & Zhang, N. (2020) · Journal of Cancer · doi:10.7150/jca.38815 · Cited by 11
Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies
Nadhan, R., Kashyap, S., Ha, J. H., Jayaraman, M., Song, Y. S., Isidoro, C., & Dhanasekaran, D. N. (2023) · Metabolites · doi:10.3390/metabo13050618 · Cited by 12
Computational modeling of cancer cell metabolism along the catabolic-anabolic axes
Castrejon, J. V., Levine, H., Kaipparettu, B. A., Onuchic, J. N., George, J. T., & Jia, D. (2025) · npj Systems Biology and Applications · doi:10.1038/s41540-025-00525-x · Cited by 10
Zhong, P., Shu, R., Wu, H., Liu, Z., Shen, X., & Hu, Y. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220975206 · Cited by 10
Zhang, Y., Mou, Y., Liang, C., Zhu, S., Liu, S., Shao, P., Li, J., & Wang, Z. (2020) · The Prostate · doi:10.1002/pros.24092 · Cited by 10
Li, Z., Su, J., Sun, M., Song, J., Sun, H., Fan, J., Chen, G., Shan, C., Qi, Q., & Zhang, S. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04171-9 · Cited by 10
Concise review: Cancer cell reprogramming and therapeutic implications
Xiao, X., Chen, H., Yang, L., Xie, G., Shimuzu, R., & Murai, A. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101503 · Cited by 10
Metabolic rewiring in MYC-driven medulloblastoma by BET-bromodomain inhibition
Graziani, V., Rodriguez‐Garcia, A., Sainero‐Alcolado, L., Guennec, A. D. L., Arsenian‐Henriksson, M., & Conte, M. R. (2023) · Scientific Reports · doi:10.1038/s41598-023-27375-z · Cited by 10
Amili, M. A., Zou, C., Xia, Y., Zeng, P., Qi, Y., Shen, Y., & Guo, S. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.144155 · Cited by 10
Kong, L., Yu, Y., Guan, H., Jiang, L., Sun, F., Li, X., Huang, W., & Li, B. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4910 · Cited by 10
Antitumor effects of a covalent cyclin-dependent kinase 7 inhibitor in colorectal cancer
Wang, J., Li, Z., Mei, H., Zhang, D., Wu, G., Zhang, T., & Lin, Z. (2019) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000749 · Cited by 10
Serinc2 Drives the Progression of Cervical Cancer Through Regulating Myc Pathway
Wang, X., Chen, J., & Li, Q. (2024) · Cancer Medicine · doi:10.1002/cam4.70296 · Cited by 9
McDermott, A., Juárez, M., Wade, M. G., Patten, S. A., & Plante, I. (2025) · Reproductive Toxicology · doi:10.1016/j.reprotox.2025.108928 · Cited by 9
Bai, M., & Sun, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.829029 · Cited by 9
Somatic mtDNA mutation burden shapes metabolic plasticity in leukemogenesis
Li-Harms, X., Lü, J., Fukuda, Y., Lynch, J., Sheth, A., Pareek, G., Kamiński, M. M., Ross, H. S., Wright, C. W., Smith, A. L., et al. (2025) · Science Advances · doi:10.1126/sciadv.ads8489 · Cited by 8
PRPS activity tunes redox homeostasis in Myc-driven lymphoma
MacMillan, A. C., Karki, B., Yang, J., Gertz, K. R., Zumwalde, S., Patel, J. A., Czyzyk-Krzeska, M., Meller, J., & Cunningham, J. T. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103649 · Cited by 8
Enhancers and MYC interplay in hematopoiesis
Benetatos, L., Benetatou, A., & Vartholomatos, G. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01891-1 · Cited by 8
Asparagine sustains cellular proliferation and c‑Myc expression in glutamine‑starved cancer cells
Chiodi, I., Perini, C., Berardi, D., & Mondello, C. (2021) · Oncology Reports · doi:10.3892/or.2021.8047 · Cited by 8
Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma
Bagaloni, I., Visani, A., Biagiotti, S., Ruzzo, A., Navari, M., Etebari, M., Mundo, L., Granai, M., Lazzi, S., Isidori, A., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.661102 · Cited by 8
Dai, Y., Zhang, J., Wang, Y., Liu, L., & Gao, J. (2022) · Journal of Molecular Modeling · doi:10.1007/s00894-022-05261-1 · Cited by 8
Metformin and glioma: Targeting metabolic dysregulation for enhanced therapeutic outcomes
Basheer, H. A., Salman, N., Abdullah, R. M., Elsalem, L., & Afarinkia, K. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102323 · Cited by 7
Li, S., Geng, S., Chen, Y., Ren, Q., Luan, Y., Liang, W., Chang, Y., Zhang, L., Zhu, D., Wu, W., et al. (2025) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2025.04.001 · Cited by 8
Bavishi, L., Butani, S., & Patel, S. S. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178198 · Cited by 8
Zhang, X., Sun, J., Zhang, P., Wen, T., Wang, R., Liang, L., Yang, Z., Li, J., Zhang, J., Che, B., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.03.022 · Cited by 7
Zhang, B., Li, X., Zhang, X., Ye, J., Zhao, W., Zhang, M., Xing, J., Qi, W., & Ye, L. (2021) · Environmental Toxicology · doi:10.1002/tox.23314 · Cited by 7
Inflammation-Associated Cytotoxic Agents in Tumorigenesis
Arnhold, J. (2023) · Cancers · doi:10.3390/cancers16010081 · Cited by 7
The potential role of glycogen metabolism in diffuse large B-cell lymphoma
Jalali, S., & Ansell, S. M. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2019.1702185 · Cited by 7
SONG, J., Liu, W., Xiao, X., Song, J., Wang, C., Gajendran, B., Wei, X., Yang, C., Chen, Y., Yang, Y., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119145 · Cited by 6
Synergistic Effect of Ribitol and Shikonin Promotes Apoptosis in Breast Cancer Cells
Doddapaneni, R., Tucker, J. D., Lu, P., & Lu, Q. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062661 · Cited by 6
The Role of Non-Coding RNAs in MYC-Mediated Metabolic Regulation: Feedback Loops and Interactions
Alamoudi, A. A. (2025) · Non-Coding RNA · doi:10.3390/ncrna11020027 · Cited by 6
Zhong, W., Ma, L., Yang, F., Cao, J., Tan, J., & Li, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1027441 · Cited by 6
Hyperthermia inhibits growth of nasopharyngeal carcinoma through degradation of c-Myc
Li, X., Duan, S., Zheng, Y., Yang, Y., Wang, L., Li, X., Zhang, Q. H., Thorne, R. F., Li, W., & Yang, D. (2022) · International Journal of Hyperthermia · doi:10.1080/02656736.2022.2038282 · Cited by 6
Ding, R., Zhou, Y., Zhang, Q., Kong, X., Li, Q., Zhang, S., Chen, Y., An, X., & Li, Z. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1507102 · Cited by 5
Key transcriptional effectors of the pancreatic acinar phenotype and oncogenic transformation
Azevedo-Pouly, A., Hale, M. A., Swift, G. H., Hoàng, C., Deering, T. G., Xue, J., Wilkie, T. M., Murtaugh, L., & MacDonald, R. J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291512 · Cited by 5
The prognostic roles of CYP19A1 expression in bladder cancer patients of different genders
Cai, S., Feng, Y., Ye, J., Deng, Y., Cai, Z., Zhu, X., Liu, R., Zhang, Y., Zou, Z., Tang, Z., et al. (2021) · Translational Andrology and Urology · doi:10.21037/tau-21-400 · Cited by 4
Geng, A., Chen, S., Ren, L., Zhao, X., Pei, T., Jia, B., & Gong, D. (2022) · Contrast Media & Molecular Imaging · doi:10.1155/2022/3517020 · Cited by 5
RetractedRAS: Circuitry and therapeutic targeting
Singh, G., Thakur, N., & Kumar, U. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110505 · Cited by 6
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic ductal adenocarcinoma
Safari, M., Scotto, L., Basseville, A., Litman, T., Xue, H., Petrukhin, L., Zhou, P., Remotti, H. E., Ku, A. W., Morales, D. V., et al. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101312 · Cited by 5
c-Myc Inhibits Macrophage Antimycobacterial Response in Mycobacterium tuberculosis Infection
Sarti, E., Dollé, C., Wolfensberger, R., Kusejko, K., Russenberger, D., Bredl, S., Speck, R. F., Greter, M., Rueschoff, J. H., Boeck, L., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf456 · Cited by 4
Chen, S., Liao, Z., Mo, J., Liu, F., Wang, W., Zhang, H., Zhang, H., Liu, Y., Pan, Y., Zhu, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64079-6 · Cited by 4
ASS1igning purine dependency to cancer
Villa, E., & Ben‐Sahra, I. (2020) · Nature Cancer · doi:10.1038/s43018-020-00117-0 · Cited by 4
Tokugawa, M., Inoue, Y., Aoki, H., Miyajima, C., Ishiuchi, K., Tsurumi, K., Kujirai, C., Morishita, D., Matsuno, M., Mizukami, H., et al. (2023) · The Journal of Biochemistry · doi:10.1093/jb/mvad085 · Cited by 4
Berberine Targets PKM2 to Activate the t-PA-Induced Fibrinolytic System and Improves Thrombosis
Sun, Z., Zhao, T., Bai, X., Li, H., Gao, J., Hao, Y., Li, Y., Xie, Y., Hu, A., Huang, Q., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17091219 · Cited by 4
Guo, J., & Lan, Z. G. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1699806 · Cited by 4
RetractedMoraleva, A. A., Антипова, Н. В., Pavlov, P., Dobrochaeva, K. L., & Rubtsov, Y. P. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1749992 · Cited by 4
Wang, T., Zhang, P., Chen, L., Qi, H., Chen, H., Zhu, Y., Zhang, L., Zhong, M., Shi, X., & Li, Q. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000837 · Cited by 2
Pyruvate kinase M2 modulates Japanese encephalitis virus replication in neuronal cells
Bohara, V. S., Deshmukh, A., & Kumar, S. (2025) · Journal of General Virology · doi:10.1099/jgv.0.002140 · Cited by 4
Engineering glutamine-regulating nanomedicines for efficient tumor therapy
Hou, G., Lu, S., Chen, Y., Lei, H., Yi, B., & Cheng, L. (2025) · Materials Today · doi:10.1016/j.mattod.2025.09.019 · Cited by 2
c-Myc: Central regulator of autophagy and senescence in cancer
Ji, S., Sun, T., Zhang, Q., Wu, M., Cao, Y., Gao, R., Wang, L., Nicot, C., & Sethi, G. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218315 · Cited by 2
Liu, X.-Z., Wang, X.-D., & Hu, M.-H. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109656 · Cited by 2
Feng, W., Lai, Y., Wang, J., & Xu, P. (2023) · PubMed Central · doi:10.12122/j.issn.1673-4254.2023.09.05 · Cited by 2
PET Agents for Primary Brain Tumor Imaging
van der Kolk, A. G., Henssen, D. J. H. A., Schroeder, H. W., & Hall, L. T. (2023) · Exon Publications eBooks · doi:10.36255/pet-agents-for-primary-brain-tumor-imaging · Cited by 2
Zeng, X., Yang, X., Zhong, Z., Lin, X., Chen, Q., Jiang, S., Mo, M., Lin, S., Zhang, H., Zhu, Z., et al. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c02765 · Cited by 2
G-quadruplex in cancer energy metabolism: A potential therapeutic target
Han, Z., & Wen, L. (2025) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2025.130810 · Cited by 2
Ma, Z., Cui, X., Lü, L., Chen, G., Yang, Y., Hu, Y., Lu, Y., Cao, Z., Wang, Y., & Wang, X. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02299-5 · Cited by 2
RetractedAcinar-to-ductal metaplasia in the pancreas requires a glycolytic switch and functional mitochondriaPreprint
Neuß, T., Wirges, N., Chen, M., Usluer, S., Oellinger, R., Lier, S., Dudek, M., Madl, T., Jastroch, M., Steiger, K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.27.495427 · Cited by 2
C-myc modulates the replication of RGNNV via glutamine-mediated ATP production in grouper fin cells
Yao, M., Chen, H., Tao, J., Wei, L., Tang, Y., Lin, J., Shi, F., Zhan, F., Li, Y., Li, J., et al. (2023) · Aquaculture and Fisheries · doi:10.1016/j.aaf.2023.05.005 · Cited by 1
Yang, M. N., Chen, Y., & Chang, M. X. (2026) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2026.111237 · Cited by 1
Monocyte Dll4 Contributes to Systemic Inflammation in People Living With HIV
Wang, S., Singh, M. V., Morrell, C. N., Yang, H., Rhen, J. M., Wang, T., Mohamad, L. A., Xu, J. J., Nguyen, T., Ture, S. K., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.326836 · Cited by 5
Molecular biomarkers in pancreatic ductal adenocarcinoma
Tsuboi, J., Yamada, R., & HIROKAWA, Y. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95114-2.00016-9 · Cited by 1
Metadata
- Authors
- Dejure, F. R., & Eilers, M.
- Affiliations
- University of Würzburg (DE)
- Corresponding author
- Eilers, Martin
- ORCID
- Eilers, Martin
- Venue
- The EMBO Journal
- Published
- 2017-12-01
- Volume
- 36
- Issue
- 23
- Pages
- 3409-3420
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC5709748
- OpenAlex
- W2767348608
- Cited by
- 240
- References
- 127
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 21 · 2023: 30 · 2022: 29 · 2021: 43 · 2020: 31 · 2019: 35 · 2018: 13
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (DFG222/12‐1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- c-Myc, cancer metabolism, metabolic reprogramming, nutrient deprivation, metabolic stress, MYC regulation, carcinogenesis
- MeSH terms
- Forkhead Box Protein O1, Mechanistic Target of Rapamycin Complex 1, Animals, Glucose, Glutamine, Humans, Neoplasms, Nucleotides, Stress, Physiological, Biogenic Polyamines, Genes, myc, Proto-Oncogene Proteins c-myc, Apoptosis, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review